In the News / Politics

Cystic Fibrosis Therapy Diminishes Hyper-Inflammation In COVID-19-Related Pneumonia

Michelle Flores, Pharm D Candidate c/o 2027 According to clinical trial results from researchers at UCL, UCLH, and the Francis…

2 years ago

FDA Accelerated Approval of Enhertu for Broad Treatment of HER2-Positive Solid Cancers

By: Nivaj Haque; PharmD Candidate c/o 2027 In recent years, advancements in oncology have transformed the treatment landscape for various…

2 years ago

FDA’s New Blueprint for Cell-Based Therapies

By: Reyaz Mussaleen PharmD Candidate c/o 2027 IntroductionThe Food and Drug Administration (FDA) of the United States published a draft…

2 years ago

An Investigation into the White House Pharmacy

By Holly Nguyen, PharmD Candidate c/o 2024 The White House Medical Unit employs a small confidential team of healthcare professionals,…

2 years ago

E.mbrace the novel E. coli Vaccine

By Ashley Dao, PharmD Candidate c/o 2024 Extraintestinal pathogenic Escherichia coli (ExPEC) is the most common gram-negative bacilli and is…

2 years ago

Carbapenem Resistant Acinetobacter Baumannii: An Urgent Threat

By: Giavanna Carr, PharmD Candidate c/o 2025 Acinetobacter is a gram-negative organism typically found in soil and water, but it…

2 years ago

Revolutionizing ADPKD Treatment: Breakthrough Drug Unveils Unprecedented Benefits

By: Bhojranie Brahmanand, PharmD Candidate c/o 2025 The most prevalent manifestation within the spectrum of polycystic kidney diseases is recognized…

2 years ago

FDA Approves Litfulo for Adults and Adolescents with Severe Alopecia Areata

By: Anjali Thykattil, PharmD Candidate c/o 2025 and Isabelle Lim, PharmD Candidate c/o 2024 Effective June 23rd, 2023, the United…

2 years ago

Roctavian, the First Gene Therapy Treatment for Hemophilia A

By: Paulina Maczko, PharmD Candidate 2027, Sarah El-Rowmeim, PharmD Candidate 2027, and Laura Pham, PharmD Candidate 2025 Valoctocogene roxaparvovec-rvox, sold…

2 years ago

FDA Approves New Weight Loss Injectable, Zepboundā„¢

By: Katelyn Hoosein, PharmD Candidate c/o 2025 and My Tram (Sophie) Le, PharmD Candidate c/o 2028 In recent years, there has…

2 years ago